The Human Medicines Regulations 2012 No. 1916

SCHEDULES

SCHEDULE 4 U.K. Standard provisions of licences under Part 3

PART 2 U.K. Manufacturer's licence relating to the import of medicinal products from a state other than an EEA State [F1 / Country other than an Approved Country for Import]

Textual Amendments

F1 Words in Sch. 4 Pt. 2 heading inserted (31.12.2020) by S.I. 2019/775, regs. 1, 20(3) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 14(c))

[F2 23B.   A licence holder may only import EAMS medicinal products if and to the extent that such products are required for the Early Access to Medicines Scheme.] U.K.

Textual Amendments

F2 Sch. 4 para. 23B inserted (15.4.2022) by The Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022 (S.I. 2022/352), regs. 1(2), 14(4) (with reg. 19)